MAWBP; MAWD binding protein; MAWD-binding protein; MAWDBP; PBLD; PBLD_HUMAN; Phenazine biosynthesis like domain containing protein; Phenazine biosynthesis like protein domain containing; Phenazine biosynthesis-like domain-containing protein; Unknown prote
Cat:
SL9032R
Species Reactivity：
(predicted: Human,Mouse,Rat,Cow,Horse,)
Immunogen：
KLH conjugated synthetic peptide derived from human PBLD/MAWBP:31-140/288
Format：
Liquid
Storage instructions：
Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Concentration：
1mg/ml
Clonality：
Polyclonal
Isotype：
IgG
Applications：
ELISA=1:5000-10000IHC-P=1:100-500IHC-F=1:100-500IF=1:50-200（Paraffin sections need to do antigen repair）not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
MAWDBP (MAWD binding protein), also known as PBLD (phenazine biosynthesis-like protein domain containing) or MAWBP, is a 288 amino acid protein that belongs to the phenazine biosynthesis-like protein (PhzF) family. It has been suggested that MAWDBP is the only representative of the PhzF family in the human genome. Expressed in most tissues, MAWDBP is a WD-40 repeat-containing β-propeller protein believed to participate in the MAPK signaling pathway. Involved in multiple basic cellular functions, expression of MAWDBP is elevated in several disease processes, including insulin resistance, folate deficiency and hypotension. It is thought that MAWDBP may also be involved in carcinogenesis.
Specific References (1) | SL9032R has been referenced in 1 publications.
[IF=2.91] Liu, Qian, et al. "Proteomic Study on Usnic Acid-induced Hepatotoxicity in Rats." Journal of agricultural and food chemistry (2012). WB ; Rat.
